CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD44 enhances tumor formation and lung metastasis in experimental osteosarcoma and is an additional predictor for poor patient outcome

Published:2013-03-18 Issue:4 Volume:28 Page:838-847
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Gvozdenovic Ana,Arlt Matthias JE,Campanile Carmen,Brennecke Patrick,Husmann Knut,Li Yufei,Born Walter,Muff Roman,Fuchs Bruno

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Osteosarcoma (osteogenic sarcoma);Picci;Orphanet J Rare Dis.,2007

2. Osteosarcoma

3. Osteosarcoma treatment: state of the art;Ta;Cancer Metastasis Rev.,2009

4. Biology and therapeutic advances for pediatric osteosarcoma;Marina;Oncologist.,2004

5. Primary bone osteosarcoma in the pediatric age: state of the art;Longhi;Cancer Treat Rev.,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma ofCS‐modified CD44 predicts the survival of patients with lung cancer;Cancer Science;2024-08-27

2. Role of CD44 in Chemotherapy Treatment Outcome: A Scoping Review of Clinical Studies;International Journal of Molecular Sciences;2024-03-08

3. A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma;Molecular Therapy;2023-08

4. Hyaluronated nanoparticles deliver raloxifene to CD44-expressed colon cancer cells and regulate lncRNAs/miRNAs epigenetic cascade;Cancer Nanotechnology;2023-04-07

5. Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process via mevalonate pathway inhibition;Materials Today Bio;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3